KLRK1 and sarcoma: Adding further complexity, although antibody-mediated NKG2D neutralisation promotes enhanced sarcoma formation in response to the chemical carcinogen 3-methylcholanthrene (3-MC) [134], NKG2D deficiency did not phenocopy this effect.